Journal: Oncotarget
Article Title: TGF-Δ isoforms in cancer: Immunohistochemical expression and Smad-pathway-activity-analysis in thirteen major tumor types with a critical appraisal of antibody specificity and immunohistochemistry assay validity
doi:
Figure Lengend Snippet: Comparative analysis of 16 tumor arrays (13 different tumor tissue types) in respect to TGF-Δ isoform expression and pathway activation
Article Snippet: The antibody panel again was extended by the following antibodies: TGF-Δ1, #MAB240, R&D Systems; TGF-Δ2, #MAB612, R&D Systems; TGF-Δ2, #ab36495, Abcam, Cambridge, UK; TGF-Δ3, #HPA27923, Sigma, St. Louis, MO.
Techniques: Expressing, Activation Assay